Advertisement
Screener

AngioDynamics, Inc. (ANGO) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax

1.7 / 5 stars · 26/77 Roast Me

AngioDynamics, Inc. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax

AngioDynamics, Inc. (ANGO) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of $0 for the 12-month period ending 2018-05-31, per its 10-K filed 2018-07-23.

Discontinued › Income Statement › Other Income

us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2018-07-23

  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2017-05-31 was $0.00, a 100.00% decline year-over-year.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2017-02-28 was $0.00, a 100.00% decline year-over-year.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2016-11-30 was $0.00, a 100.00% decline year-over-year.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2016-08-31 was $0.00, a 100.00% decline year-over-year.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2018 was $0.00.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2016 was $257.00K, a 13.18% decline from fiscal 2015.
  • AngioDynamics, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2015 was $296.00K.
Period endOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 monthOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 month as first filedOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 6 monthOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 9 monthOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month
2018-05-31$0.00
10-K · filed 2018-07-23
2017-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23
$0.00
derived: sum of 2 quarters · filed 2018-07-23
$0.00
derived: sum of 3 quarters · filed 2018-07-23
$0.00
10-K · filed 2018-07-23
2017-02-28$0.00
10-Q · filed 2017-04-03
$0.00
derived: sum of 2 quarters · filed 2017-04-03
$0.00
10-Q · filed 2017-04-03
$38.00K
derived: sum of 4 quarters · filed 2018-07-23
2016-11-30$0.00
10-Q · filed 2017-01-06
$0.00
10-Q · filed 2017-01-06
$38.00K
derived: sum of 3 quarters · filed 2018-07-23
$96.00K
derived: sum of 4 quarters · filed 2018-07-23
2016-08-31$0.00
10-Q · filed 2016-10-05
$38.00K
derived: sum of 2 quarters · filed 2018-07-23
$96.00K
derived: sum of 3 quarters · filed 2018-07-23
$186.00K
derived: sum of 4 quarters · filed 2018-07-23
2016-05-31$38.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23
$96.00K
derived: sum of 2 quarters · filed 2018-07-23
$186.00K
derived: sum of 3 quarters · filed 2018-07-23
$257.00K
10-K · filed 2018-07-23
2016-02-29$58.00K
10-Q · filed 2017-04-03
$148.00K
derived: sum of 2 quarters · filed 2017-04-03
$219.00K
10-Q · filed 2017-04-03
$221.00K
derived: sum of 4 quarters · filed 2017-08-04
2015-11-30$90.00K
10-Q · filed 2017-01-06
$156.00K
10-Q · filed 2017-01-06
$163.00K
derived: sum of 3 quarters · filed 2017-08-04
$296.00K
derived: sum of 4 quarters · filed 2017-08-04
2015-08-31$66.00K
10-Q · filed 2016-10-05
$73.00K
derived: sum of 2 quarters · filed 2017-08-04
$206.00K
derived: sum of 3 quarters · filed 2017-08-04
$181.00K
derived: sum of 4 quarters · filed 2017-08-04
2015-05-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-04
$140.00K
derived: sum of 2 quarters · filed 2017-08-04
$115.00K
derived: sum of 3 quarters · filed 2017-08-04
$296.00K
10-K · filed 2017-08-04
2015-02-28$133.00K
10-Q · filed 2016-04-11
$108.00K
derived: sum of 2 quarters · filed 2016-04-11
$289.00K
10-Q · filed 2016-04-11
$328.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30-$25.00K
10-Q · filed 2016-01-08
$156.00K
10-Q · filed 2016-01-08
$195.00K
derived: sum of 3 quarters · filed 2016-08-01
$327.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31$181.00K
10-Q · filed 2015-10-08
$220.00K
derived: sum of 2 quarters · filed 2016-08-01
$352.00K
derived: sum of 3 quarters · filed 2016-08-01
-$170.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-05-31$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
$171.00K
derived: sum of 2 quarters · filed 2016-08-01
-$351.00K
derived: sum of 3 quarters · filed 2016-08-01
-$32.00K
10-K · filed 2016-08-01
2014-02-28$132.00K
10-Q · filed 2014-04-09
-$390.00K
derived: sum of 2 quarters · filed 2015-04-09
-$71.00K
10-Q · filed 2015-04-09
$278.00K
derived: sum of 4 quarters · filed 2015-08-10
2013-11-30-$522.00K
10-Q · filed 2015-01-09
-$203.00K
10-Q · filed 2015-01-09
$146.00K
derived: sum of 3 quarters · filed 2015-08-10
$333.00K
derived: sum of 4 quarters · filed 2015-08-10
2013-08-31$319.00K
10-Q · filed 2014-10-15
$668.00K
derived: sum of 2 quarters · filed 2015-08-10
$855.00K
derived: sum of 3 quarters · filed 2015-08-10
$1.01M
derived: sum of 4 quarters · filed 2015-08-10
2013-05-31$349.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-10
$536.00K
derived: sum of 2 quarters · filed 2015-08-10
$687.00K
derived: sum of 3 quarters · filed 2015-08-10
-$522.00K
10-K · filed 2015-08-10
2013-02-28$187.00K
10-Q · filed 2013-04-09
$338.00K
derived: sum of 2 quarters · filed 2014-04-09
-$871.00K
10-Q · filed 2014-04-09
-$363.00K
derived: sum of 4 quarters · filed 2015-01-12
2012-11-30$151.00K
10-Q · filed 2014-01-09
$29.00K
10-Q · filed 2013-01-09
-$1.06M
10-Q · filed 2013-01-09
-$550.00K
derived: sum of 3 quarters · filed 2015-01-12
-$553.00K
derived: sum of 4 quarters · filed 2015-01-12
2012-08-31-$1.09M
10-Q/A · filed 2012-11-09
-$701.00K
derived: sum of 2 quarters · filed 2015-01-12
-$704.00K
derived: sum of 3 quarters · filed 2015-01-12
-$702.00K
derived: sum of 4 quarters · filed 2015-01-12
2012-05-31$387.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-12
$384.00K
derived: sum of 2 quarters · filed 2015-01-12
$386.00K
derived: sum of 3 quarters · filed 2015-01-12
$327.00K
10-K · filed 2015-01-12
2012-02-29-$3.00K
10-Q · filed 2013-04-09
-$1.00K
derived: sum of 2 quarters · filed 2013-04-09
-$60.00K
10-Q · filed 2013-04-09
2011-11-30$2.00K
10-Q · filed 2013-01-09
-$57.00K
10-Q · filed 2013-01-09
2011-08-31-$59.00K
10-Q/A · filed 2012-11-09
2011-05-31$5.00K
10-K · filed 2013-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82